Newly created Aralez Pharmaceuticals opens TSX

Aralez Pharmaceuticals Inc (TSX: ARZ), launched in February with a investment led by Deerfield Management, opened the market on April 5th. Aralez, an Ontario domiciled pharmaceutical business focused on developing products for cardiovascular, pain and other specialty areas, emerged from a merger of POZEN Inc and Tribute Pharmaceuticals Canada Inc. The Deerfield-led consortium committed up to US$350 million to the new company.

DealsCanadaNorth AmericaBriefs